Formulation and method to induce a deep state of relaxation

Abstract

A relaxation formulation structured to induce a deep state of relaxation in a person comprises amounts of tryptophan, melatonin, vitamin B3, and vitamin B6. Another relaxation formulation also includes an amount of tyrosine, and yet another formulation includes an amount of vitamin B12. At least one embodiment of a relaxation formula comprises a physiologically effective amount of gamma-aminobutyric acid (“GABA”). A delivery system is provided to facilitate administration of the relaxation formulation to a person. The delivery system may include an edible high carbohydrate matrix, such as a chocolate brownie. Alternatively, the delivery system may comprise an inert vaporizable compound to allow the components of the relaxation formulation to be inhaled directly into the lungs of a person. Other delivery systems include an aqueous sublingual spray and a beverage.

What is claimed is: 
     
         1 . A relaxation formulation dissolved into an inert vaporizable compound to be inhaled directly into a person's lungs and induce a deep state of relaxation in the person, said relaxation formulation comprising:
 an amount of L-tryptophan of about 1 to 5 milligrams per milliliter,   an amount of melatonin of about 1 to 5 milligrams per milliliter,   an amount of gamma-aminobutyric acid of about 1 to 5 milligrams per milliliter, and   wherein said amount of melatonin relative to said amount of L-tryptophan is in a ratio of about 1:1.   
     
     
         2 . The formulation as recited in  claim 1  wherein said amount of L-tryptophan is about 1 milligram per milliliter. 
     
     
         3 . The formulation as recited in  claim 1  wherein said amount of gamma-aminobutyric acid relative to said amount of L-tryptophan is in a ratio of about 1:1. 
     
     
         4 . The formulation as recited in  claim 3  wherein said amount of L-tryptophan is about 1 milligram per milliliter. 
     
     
         5 . A method for inducing a deep state of relaxation in a person comprising the step of:
 administering a relaxation formulation to the person by dissolving the relaxation formation into an inert vaporizable compound and vaporizing the inert vaporizable compound via exposure to a heat source for inhalation directly into the lungs of the person, wherein the relaxation formulation comprises a predetermined amount of each of tryptophan, melatonin, and gamma-aminobutyric acid, and wherein the amount of melatonin relative to the amount of L-tryptophan is in a ratio of about 1:1.   
     
     
         6 . The method as recited in  claim 5  wherein the heat source comprises an electronic cigarette. 
     
     
         7 . The method as recited in  claim 6  wherein the predetermined amount of L-tryptophan is about 1 milligram per milliliter. 
     
     
         8 . The method as recited in  claim 5  wherein the amount of gamma-aminobutyric acid relative to the amount of L-tryptophan is in a ratio of about 1:1. 
     
     
         9 . The method as recited in  claim 8  wherein the amount of L-tryptophan is about 1 milligram per milliliter. 
     
     
         10 . The method as recited in  claim 9  wherein the heat source comprises an electronic cigarette.